The European Court of Justice has ruled in favour of a ban on patent protection for embryonic stem cell lines.
The decision on the ban has been pending since April 2011, and yesterday the court ruled any invention based on human embryonic stem cells is unethical and therefore cannot be patented.
Go deeper with GlobalData
Scientists have expressed their disappointment over the news, including Dr David Hay, Principal Investigator within the Pluripotent Stem Cell Hepatocyte Development at the University of Edinburgh.
He said: "The ruling will have major implications for the commercialisation of stem cell based technologies in the EU and worryingly, create the idea that stem cell research is immoral.
"This will undoubtedly have a negative impact on the clinical translation of the basic and world leading research carried out in Europe and delay the delivery of cutting edge treatments to the patient," added Hay.
See Also:
A University College London researcher said the ruling casts "real doubt" on the possibility of new medicines from stem cell research.
How well do you really know your competitors?
Access the most comprehensive Company Profiles on the market, powered by GlobalData. Save hours of research. Gain competitive edge.
Thank you!
Your download email will arrive shortly
Not ready to buy yet? Download a free sample
We are confident about the unique quality of our Company Profiles. However, we want you to make the most beneficial decision for your business, so we offer a free sample that you can download by submitting the below form
By GlobalDataHe explained: "Getting a stem cell technique to cure blindness is fantastic, but it may never get out as a medicine because no manufacturer will get any financial reward from it."
